Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT01262820
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older
* Stage IIIB (with malignant pleural or pericardial effusion or supraclavicular lymph node involvement) or stage IV NSCLC
* Evidence of progression while on bevacizumab
* Patients treated for CNS metastases who are asymptomatic with no requirement for steroids for 2 weeks prior to first dose of study drug
Exclusion Criteria:
* Prior malignancy
* Clinically significant gastrointestinal abnormalities
* Presence of uncontrolled infection or nonhealing wound, fracture, or ulcer
* History of cardiovascular conditions within the past 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01262820
Study Brief:
Protocol Section:
NCT01262820